百济神州在美国专利纠纷中获胜,USPTO裁定相关专利无效

新浪财经
Yesterday

4月30日,百济神州公告表示,美国专利商标局(USPTO)近日作出决定,宣告Pharmacyclics公司持有的第11672803号美国专利(以下简称“803专利”)全部权利要求无效。这一裁定源于百济神州及其美国子公司与Pharmacyclics之间的一场专利纠纷。2023年6月,Pharmacyclics在美国特拉华州地方法院对百济神州提起诉讼,指控其核心产品泽布替尼侵犯了当日新获授权的“803...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10